Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate + simvastatin versus atorvastatin in mixed dyslipidemia inadequately controlled by atorvastatin 10 mg
2006-000519-21Phase 3Completed
- Sponsor
- Fournier Laboratories Ireland
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fenofibrate, simvastatin and atorvastatin in combined dyslipidaemia (4 arms), sponsored by Fournier Laboratories Ireland. Primary endpoints: Percent change in triglycerides, Percent change in HDL cholesterol and 1 more. Started May 2006; status: completed.
02
Drugs
fenofibratesimvastatinatorvastatin
03
Conditions
combined dyslipidaemia
Beyond the preview
Go deeper on 2006-000519-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000519-21.